Status:
UNKNOWN
Cognitive Rehabilitation in Patients With Depression
Lead Sponsor:
Lovisenberg Diakonale Hospital
Collaborating Sponsors:
University of Oslo
Yale University
Conditions:
Depression
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Depression is a highly prevalent and debilitating mental disorder, ranked one of the leading causes of disability worldwide. Several studies have identified neuropsychological deficits in populations ...
Eligibility Criteria
Inclusion
- Completed treatment for mild or moderate MDD
- Evidence of executive dysfunction in everyday life determined by (a) a structured interview or (b) a self-report Behavior Rating Inventory of Executive Function (BRIEF) T-score \< 55.
Exclusion
- Cognitive, sensory, physical, or language impairment affecting the capacity to complete the training program.
- Premorbid neurological disease or insult and/or comorbid neurological disorder.
- Reported ongoing alcohol or substance abuse.
- Psychotic disorders.
- Actively suicidal.
- Personality disorder sever enough to interfere with the protocol.
- Not fluent in Norwegian language.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03338413
Start Date
January 1 2018
End Date
June 1 2020
Last Update
November 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lovisenberg Diaconal Hospital
Oslo, Norway